Genocea Biosciences, Inc.

OTCPK:GNCA.Q Voorraadrapport

Marktkapitalisatie: US$5.9k

Genocea Biosciences Beheer

Beheer criteriumcontroles 2/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Chip Clark

Algemeen directeur

US$3.8m

Totale compensatie

Percentage CEO-salaris15.2%
Dienstverband CEO12.3yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn7.3yrs
Gemiddelde ambtstermijn bestuur8.7yrs

Recente managementupdates

Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet

Jun 17
Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet

Recent updates

Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet

Jun 17
Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet

What Type Of Returns Would Genocea Biosciences'(NASDAQ:GNCA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 18
What Type Of Returns Would Genocea Biosciences'(NASDAQ:GNCA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

How Much Of Genocea Biosciences, Inc. (NASDAQ:GNCA) Do Institutions Own?

Jan 14
How Much Of Genocea Biosciences, Inc. (NASDAQ:GNCA) Do Institutions Own?

Analyse CEO-vergoeding

Hoe is Chip Clark's beloning veranderd ten opzichte van Genocea Biosciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$4mUS$571k

-US$33m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$36m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020US$1mUS$551k

-US$44m

Sep 30 2020n/an/a

-US$38m

Jun 30 2020n/an/a

-US$41m

Mar 31 2020n/an/a

-US$36m

Dec 31 2019US$1mUS$533k

-US$39m

Sep 30 2019n/an/a

-US$29m

Jun 30 2019n/an/a

-US$30m

Mar 31 2019n/an/a

-US$27m

Dec 31 2018US$1mUS$515k

-US$28m

Sep 30 2018n/an/a

-US$39m

Jun 30 2018n/an/a

-US$48m

Mar 31 2018n/an/a

-US$59m

Dec 31 2017US$2mUS$493k

-US$57m

Sep 30 2017n/an/a

-US$62m

Jun 30 2017n/an/a

-US$58m

Mar 31 2017n/an/a

-US$54m

Dec 31 2016US$1mUS$455k

-US$50m

Compensatie versus markt: Chip's total compensation ($USD3.75M) is above average for companies of similar size in the US market ($USD740.57K).

Compensatie versus inkomsten: Chip's compensation has increased whilst the company is unprofitable.


CEO

Chip Clark (53 yo)

12.3yrs

Tenure

US$3,750,857

Compensatie

Mr. William D. Clark, M.B.A., also known as Chip, has been an Independent Director at iBio, Inc. since August 26, 2021 and serves as its Chairman since November 2022. He has been the Director, Chief Execut...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
William Clark
President12.3yrsUS$3.75mgeen gegevens
Jessica Flechtner
Chief Scientific Officer7.3yrsUS$1.27mgeen gegevens
Diantha Duvall
CFO & Secretary4.2yrsgeen gegevensgeen gegevens

7.3yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: GNCA.Q's management team is seasoned and experienced (7.3 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
William Clark
President12.3yrsUS$3.75mgeen gegevens
Kenneth Bate
Independent Chairman of the Board8.7yrsUS$120.98kgeen gegevens
Michael Higgins
Independent Director8.3yrsUS$78.48kgeen gegevens
Katrine Bosley
Independent Director10.2yrsUS$75.88kgeen gegevens
George R. Siber
Independent Chairman of Scientific Advisory Board & Director16.3yrsUS$66.98kgeen gegevens
Kwok-Kin Wong
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Jennifer Herron
Independent Director1.7yrsUS$61.50kgeen gegevens
Marcela Maus
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Eric Tran
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Elizabeth Jaffee
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
John Lunger
Independent Director1.2yrsgeen gegevensgeen gegevens

8.7yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren bestuur: GNCA.Q's board of directors are considered experienced (8.7 years average tenure).